Concentrations of soluble forms of adhesive particles: sVCAM-1, sPECAM-1, sVAP in early localized and late disseminated borreliosis;Stȩżenie rozpuszczalnych form cza̧steczek adhezyjnych sVCAM-1, sPECAM-1, sVAP w boreliozie, w postaci wczesnej zlokalizowanej i rozsianej

Polski Merkuriusz Lekarski

Volumn 21, Issue 125, 2006, Pages 459-464

  Zajkowska, Joanna ^a   Grygorczuk, Sambor ^a   Kondrusik, Maciej ^a   Pancewicz, Sławomir ^a   Jamiołkowski, Jacek ^a,b   Muszyńska, Agnieszka ^a,b   Hermanowska Szpakowicz, Teresa ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Zakład Zdrowia Publicznego ^*

Author keywords

Lyme borreliosis; sPECAM; sVAP; sVCAM

Indexed keywords

ADHESIVE AGENT; VASCULAR ADHESION PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1; AMINE OXIDASE (COPPER CONTAINING); AOC3 PROTEIN, HUMAN; BIOLOGICAL MARKER; CD31 ANTIGEN; CELL ADHESION MOLECULE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD DONOR; BORRELIA INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LYME DISEASE; PROTEIN LOCALIZATION; ROC CURVE; ANIMAL; BLOOD; FEMALE; MALE; MIDDLE AGED; SOLUBILITY; TICK;

AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; ANTIGENS, CD31; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; FEMALE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; SOLUBILITY; TICKS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33845317249     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Akin E., Aversa J., Steere A.: Expression of adhesion molecules in synovia of patients with treatment resistant Lyme arthritis. Infect. Immun., 2001, 69, 3, 1774-1780.
2. Boggenmeyer E., Stehle T., Schaible U.E., i wsp.: Borrelia burgdorferi upregulates the adhesion molecules E-sellectin, P-selectin, ICAM-1 and VCAM-1 on mouse endothelioma cells in vitro. Cell Adhes. Commun., 1994, 2, 145-157.
3. Carlos T.M., Harlan J.M.: Leukocyte-endothelial adhesion molecules. Blood, 1994, 84, 2068-2101.
4. Carlos T.M., . Schwartz B.R., . Kovach N.L. i wsp.: Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood, 1990. 76, 965.
5. Faveeuw C., Di Mauro M., Price A.A., i wsp.: Roles of alfa 4 integrins/VCAM-1 and LFA-1/ICAM-1 in the binding and transendothelial migration of T lymphocytes and T lymphoblasts across high endotelial venules. Int. Immunology, 2000, 12, 3, 241-251.
6. Fota-Markowska H., Modrzewska R., Bielec D. i wsp.: Stȩżenie sVAP-1 w surowicy w wybranych postaciach klinicznych boreliozy z Lyme. Przegl. Epidemiol., 2002, suppl. 1, 56, 79-85.
7. Gearing A.J., Newman W.: Circulating adhesion molecules in disease. Immunol. Today, 1993, 14, 506-512.
8. Goldberger A., Middleton K.A., . Oliver J.A. i wsp.: Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J. Biol. Chem., 1994, 269, 17183-17191.
9. Hermanowska-Szpakowicz T., Zajkowska J.M., Pancewicz S. i wsp.: Pathogenetic-clinical problems of Lyme borreliosis. Neurol. Neurochir. Pol., 2003, 37 suppl. 2, 29-38.
10. Iżycka A., Jabłońska E., Ziarko S. i wsp.: Expression of PECAM on TNF alfa, and IFN- gamma stimulated neutrophils and sPECAM soluble form concentration in the serum of patients with Lyme borreliosis. Ann. Agricultur Environ. Med., (w druku).
11. Iżycka A., Jabłońska E.: Rola cza̧jsteczek adhezyjnych w chorobie nowotworowej. Pol. Merk. Lek., 2002, 76, 345-348.
12. Klimiuk P.A., Sierakowski S., Latosiewicz R., i wsp.: Soluble adhesion molecules ICAM-1, VCAM-1, and E-selectin and vascular endothelial growth factor, VEGF in patients with distinct variants of rheumatoid synovitis. Ann. Rheum. Dis., 2002, 61, 804-809.
13. Kulander L., Pauksens K, Venge P.: Soluble adhesion molecules, cytokines and cellular markers in serum in patients with acute infections. Scand. J. Infect. Dis., 2001, 33, 4, 290-300.
14. Michałowska-Wender G., Losy J., Kondrusik M. i wsp.: Badanie stȩżenia rozpuszczonej cza̧steczki adhezyjnej sPECAM-1 oraz chemokiny MCP-1 w PMR u chorych z KZM. Pol. Merk. Lek., 2006, 115, 46-48.
15. Muller W.A., Weigl S.A., Deng X. i wsp.: PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med., 1993, 178, 449-460.
16. Osborn L: Leukocyte adhesion to endothelium in inflammation. Cell, 1990, 62, 3-6.
17. Panes J., Perry M., Granger D.N.: Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br. J. Pharmacol., 1999, 126, 537-550.
18. Salmi M., Raajala M., Jalkaren S.: Homing of mucosal leukocytes in joints. J. Clin. Invest., 1997, 99, 2165-2172.
19. Schaible U.E., Vesweber D., Butcher E.G. , i wsp.: Expression of endothelial cell adhesion molecules in joints and heart during Borrelia burgdorferi infection in mice. Cell Adhes. Commun., 1994, 2, 6, 465-479.
20. Sellati T.J., Burns M.J., Ficazzola M. i wsp.: Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Inf. Immun., 1995, 4439-4447.
21. Sharar S.R., Winn R.K., Harlan J.M.: The adhesion cascade and anti-adhesion therapy: An overview. Springer Semin. Immunopathol., 1995. 16, 359.
22. Tang D.G., Chen Y.Q., Newman P.J. i wsp.: Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. J. Biol. Chem., 1993, 268, 22883-22894.
23. Zajkowska J.M., Hermanowska-Szpakowicz T.: Nowe aspekty patogenetyczne boreliozy z Lyme. Przegl. Epidemiol., 2002, 56 , 1, 57-67.
24. Zajkowska J.M., Iżycka A., Jabłonska E. i wsp.: Stȩżenie w surowicy i płynie mozgowo-rdzeniowymsICAM-1 sICAM-2, sICAM-3 w neuroboreliozie i kleszczowym zapaleniu mózgu - doniesienie wstepne. Pol. Merk. Lek., 2005, 19 110, 152-157.